Flu Vaccine Reinvented

Posted by Leanne Kodsman on

As the flu season is in full swing across the United States, scientists are looking at better methods to provide the population with stronger immunity, as outlined in a recent article by ScienceNews.

In general, vaccines protect from illness by stimulating antibodies in order to block viruses. When it comes to the flu, however, this approach is not always as effective as we'd hope - influenza antibodies are strain-specific, and the flu shot is formulated to protect against the most likely strains.


As the flu season is in full swing across the United States, scientists are looking at better methods to provide the population with stronger immunity, as outlined in a recent article by ScienceNews.

In general, vaccines protect from illness by stimulating antibodies in order to block viruses. When it comes to the flu, however, this approach is not always as effective as we'd hope - influenza antibodies are strain-specific, and the flu shot is formulated to protect against the most likely strains.

While this definitely does much of the heavy lifting (seriously, get your flu shot!), every year there are strains that emerge that are not included in the vaccine. This can lead to widespread outbreaks of influenza across broad sections of the country.

Taking a different approach, researchers are looking to develop a flu vaccine that will keep influenza viruses from escaping the body's first line of defense - a powerful antiviral system that includes various immune proteins and cells.

Making the influenza virus more visible to the immune system will help to bring about a strong immune response, helping the body to fight the virus more effectively.

Called the hyper-interferon-sensitive (HIS) virus, this new method of vaccination is showing promise. In a recent study, mice infected with HIS survived exposure to lethal doses of several different strains of influenza A, while the majority of those exposed without HIS vaccination did not survive.

Researchers were able to exploit vulnerabilities in the genetic material of the influenza virus, creating a weakened version for vaccination purposes that is still able to jump-start the immune system. This approach could also be useful for creating more effective vaccines for other viruses, as well.

Find out more about the efforts to create a universal flu vaccine, and enjoy the full article on ScienceNews.


Innovative Research has been supplying dependable, high-quality, and affordable research materials for the past 20 years. Beginning with core products like human plasma and serum, Innovative Research has grown to become a trusted supplier of all lab reagents, including human biologicals and ELISA kits. Today we manufacture and supply thousands of high-quality human and animal biologicals including plasma, serum, tissues, and proteins.


    Innovative Research was established in 1998 after the realization that dependable, high-quality, and affordable research materials were hard to come by. Starting with core products like human plasma and serum, Innovative Research has grown to be a trusted supplier of all lab reagents, including human biologicals and ELISA kits. Today, we manufacture and supply thousands of high-quality human and animal biologicals including plasma, serum, tissues, and proteins.


Related Posts

Antigen, Abbreviated: Plasminogen Activator Inhibitor 1 (PAI-1)
What is PAI-1 and what does it do? Plasminogen Activator Inhibitor 1, commonly referred...
Read the Article
Specialized Biologicals for Your Research
With such a large catalog of available products, we've been working on creating meaning...
Read the Article
Post-Doctorate Grant Opportunity to Fund Innovative Research in the Life Sciences
At Innovative Research, Inc. we fully believe in the importance of funding innovative r...
Read the Article

← Older Post Newer Post →